ABCD1 p.Asp194His
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 21476988
[PubMed]
Zhang X et al: "Conservation of targeting but divergence in function and quality control of peroxisomal ABC transporters: an analysis using cross-kingdom expression."
No.
Sentence
Comment
153
Approximately 60% of X-ALD ABCD1 mutations are missense mutations, 65% of which result in no detectable ALDP, based on IF (immunofluorescence), indicating that they affect protein Table 1 Quantification of ALDP levels in X-ALD fibroblasts ALDP Mutation IF Immunoblot (% of control) p.Arg74Trp Absent 7.5 + - 0.6 p.Arg104Cys Reduced 35 + - 3.0 p.Ser149Asn Present 77 + - 3.0 p.Asp194His Present 60 + - 13.6 p.Leu220Pro Reduced 21.8 + - 5.4 p.Arg389His Present 40.6 + - 3.6 p.Arg554His Absent 1.0 + - 0.5 p.Ser606Leu Present 25 + - 1.5 p.Glu609Gly Absent 2.1 + - 1.3 p.Glu609Lys Absent 1.8 + - 0.9 p.Ala616Thr Absent 4.3 + - 1.7 p.Leu654Pro Absent 1.5 + - 1.3 p.Arg660Trp Absent 1.6 + - 0.8 p.His667Asp Absent 2.9 + - 1.0 p.Arg113fs Absent - Figure 3 Interaction of mammalian ABCD proteins with Arabidopsis Pex19 in vivo Tobacco plants stably expressing CFP-SKL were co-transfected with 35S::ABCD-YFP fusions andNLS-Pex19constructs.Leafepidermalcellswereimagedusingconfocalmicroscopy:(A-D) ALDP-YFP plus NLS-HsPex19; (E-H) ALDP-YFP plus NLS-AtPex19_1; (I-L) ALDR-YFP plus NLS-AtPex19_1.
X
ABCD1 p.Asp194His 21476988:153:376
status: NEW172 ALDP was increased from 2-4% to ~20% of wild-type levels in cell lines bearing the mutations p.Glu609Gly, p.Ala616Thr and p.Arg660Trp, from 1 to 10% in p.Glu609Lys and p.Arg554His cells and from 45 to 75% in the p.Asp194His cell line (Figure 4A).
X
ABCD1 p.Asp194His 21476988:172:214
status: NEW173 VLCFA β-oxidation was measured in cells that were cultured at 30◦ C for 72 h, but in only one case (p.Ala616Thr) was the capacity to degrade VLCFA restored to near-control levels (Figure 4C).
X
ABCD1 p.Asp194His 21476988:173:214
status: NEW176 Lines bearing the p.Glu609Gly and p.Asp194His mutations did not show any correction of the C26:0/C22:0 ratio (Figure 4D).
X
ABCD1 p.Asp194His 21476988:176:36
status: NEW154 Approximately 60% of X-ALD ABCD1 mutations are missense mutations, 65% of which result in no detectable ALDP, based on IF (immunofluorescence), indicating that they affect protein Table 1 Quantification of ALDP levels in X-ALD fibroblasts ALDP Mutation IF Immunoblot (% of control) p.Arg74Trp Absent 7.5 + - 0.6 p.Arg104Cys Reduced 35 + - 3.0 p.Ser149Asn Present 77 + - 3.0 p.Asp194His Present 60 + - 13.6 p.Leu220Pro Reduced 21.8 + - 5.4 p.Arg389His Present 40.6 + - 3.6 p.Arg554His Absent 1.0 + - 0.5 p.Ser606Leu Present 25 + - 1.5 p.Glu609Gly Absent 2.1 + - 1.3 p.Glu609Lys Absent 1.8 + - 0.9 p.Ala616Thr Absent 4.3 + - 1.7 p.Leu654Pro Absent 1.5 + - 1.3 p.Arg660Trp Absent 1.6 + - 0.8 p.His667Asp Absent 2.9 + - 1.0 p.Arg113fs Absent - Figure 3 Interaction of mammalian ABCD proteins with Arabidopsis Pex19 in vivo Tobacco plants stably expressing CFP-SKL were co-transfected with 35S::ABCD-YFP fusions andNLS-Pex19constructs.Leafepidermalcellswereimagedusingconfocalmicroscopy:(A-D) ALDP-YFP plus NLS-HsPex19; (E-H) ALDP-YFP plus NLS-AtPex19_1; (I-L) ALDR-YFP plus NLS-AtPex19_1.
X
ABCD1 p.Asp194His 21476988:154:376
status: NEW177 Lines bearing the p.Glu609Gly and p.Asp194His mutations did not show any correction of the C26:0/C22:0 ratio (Figure 4D).
X
ABCD1 p.Asp194His 21476988:177:36
status: NEW
PMID: 11063720
[PubMed]
Unterrainer G et al: "Co-expression of mutated and normal adrenoleukodystrophy protein reduces protein function: implications for gene therapy of X-linked adrenoleukodystrophy."
No.
Sentence
Comment
45
We also transfected one of these cell lines, D194H, with an haemagglutinin (HA)-tagged normal construct to investigate the influence of mutated ALDP on correct peroxisomal targeting of normal ALDP when both are present in the same cell, a situation expected after gene transfer into autologous bone marrow cells of some X-ALD patients.
X
ABCD1 p.Asp194His 11063720:45:45
status: NEW49 Average transfection efficiency was determined in three independent experiments and was 14% for the ALDP-deficient cell line (range 10-17%), 20% for the D194H cell line (range 15-23%), 26% for the S213C cells and 24% for the N148S cell line (range 22-30%).
X
ABCD1 p.Asp194His 11063720:49:153
status: NEW51 Transient transfection of normal ALD cDNA into X-ALD fibroblast cell lines: A626T lack detectable ALDP, whereas N148S, D194H and S312C cell lines produce stable, mutated ALDP.
X
ABCD1 p.Asp194His 11063720:51:119
status: NEW56 To be able to further distinguish between endogenously expressed normal ALDP and mutated ALDP, a 9 amino acid motif from the influenza haemagglutinin protein was added to the C-terminus of D194H ALDP.
X
ABCD1 p.Asp194His 11063720:56:189
status: NEW59 HeLa Tet-on cells were transfected with HA-tagged D194H-ALD cDNA and stable transformants were selected.
X
ABCD1 p.Asp194His 11063720:59:50
status: NEW60 PCR analysis confirmed the presence of both endogenous ALD gene and integrated D194H-ALD cDNA.
X
ABCD1 p.Asp194His 11063720:60:79
status: NEW61 Based on indirect immunofluorescence studies one clone, HeLa-D194H, which showed low background expression and high inducibility, was finally selected.
X
ABCD1 p.Asp194His 11063720:61:61
status: NEW63 No staining outside the peroxisomes above typical cellular background staining could be observed, indicating that overexpression of D194H-ALDP did not alter its localization.
X
ABCD1 p.Asp194His 11063720:63:132
status: NEW66 Induction of D194H-ALD expression was verified by analysing mRNA and protein levels of both normal and mutated ALDP.
X
ABCD1 p.Asp194His 11063720:66:13
status: NEW67 Northern blot analysis of the HeLa-D194H clone at various concentrations of doxycycline showed robust induction even at the lowest concentration (Fig. 3a).
X
ABCD1 p.Asp194His 11063720:67:35
status: NEW70 Concerning the ratio of normal to mutated ALD mRNA, in HeLa-D194H without doxycycline the level of mutated ALD mRNA was ~30% of the level of endogenous ALD mRNA.
X
ABCD1 p.Asp194His 11063720:70:60
status: NEW75 Western blot analysis was performed with HeLa-D194H cells at varying concentrations of doxycycline (Fig. 4).
X
ABCD1 p.Asp194His 11063720:75:46
status: NEW77 Indirect immunofluorescence analysis of the HA-tagged D194H-ALDP in doxycycline-induced HeLa-D194H cells.
X
ABCD1 p.Asp194His 11063720:77:54
status: NEWX
ABCD1 p.Asp194His 11063720:77:93
status: NEW80 Northern blot analysis of HeLa cells stably expressing mutated D194H-ALDP.
X
ABCD1 p.Asp194His 11063720:80:63
status: NEW99 Mutated D194H-ALDP was induced by different doxycycline concentrations (Fig. 5a).
X
ABCD1 p.Asp194His 11063720:99:8
status: NEW100 A slight decrease in β-oxidation was observed for uninduced HeLa-D194H cells and after induction with the lowest doxycycline concentration.
X
ABCD1 p.Asp194His 11063720:100:70
status: NEW101 Compared with normal HeLa Tet-on cells, the decrease for both uninduced and slightly induced HeLa-D194H cells was not statistically significant.
X
ABCD1 p.Asp194His 11063720:101:98
status: NEW102 When expression of D194H-ALDP was further upregulated by higher doxycycline concentrations the rate of β-oxidation was markedly reduced and this reduction was statistically significant compared with normal HeLa Tet-on cells.
X
ABCD1 p.Asp194His 11063720:102:19
status: NEW103 Thus, overexpression of mutated D194H-ALDP is sufficient to reduce β-oxidation in HeLa Tet-on cells.
X
ABCD1 p.Asp194His 11063720:103:32
status: NEW104 In the induced HeLa-D194H cells the overall reduction in the rate of β-oxidation was ~45%, which is a less severe effect than the reduction of ~80% for X-ALD fibroblasts compared with healthy fibroblasts (Fig. 5a).
X
ABCD1 p.Asp194His 11063720:104:20
status: NEW106 Western blot analysis of HeLa-D194H cells induced with increasing concentrations of doxycycline.
X
ABCD1 p.Asp194His 11063720:106:30
status: NEW118 (b) Gas chromatographic analysis of VLCFA levels displayed as ratio of C26:0/C22:0 accumulation in HeLa-D194H and HeLa Tet-on control cells cultured in the presence of the indicated doxycycline concentrations for 1 week.
X
ABCD1 p.Asp194His 11063720:118:104
status: NEW120 To establish whether the decreased rate of β-oxidation also leads to intracellular accumulation of very long chain fatty acids, expression of D194H-ALDP was induced in HeLa-D194H cells for 1 week and the content of VLCFA was determined by gas chromatography.
X
ABCD1 p.Asp194His 11063720:120:147
status: NEWX
ABCD1 p.Asp194His 11063720:120:148
status: NEW123 In contrast, more pronounced expression of mutated D194H-ALDP at 2 or 5 µg/ml doxycycline resulted in a 7-fold increase in the accumulation of VLCFA compared with untreated cells.
X
ABCD1 p.Asp194His 11063720:123:51
status: NEW137 To further elucidate the mechanism of interaction between normal and mutated ALDP, we constructed a HeLa Tet-on cell line with D194H mutated ALDP under a strong inducible promoter.
X
ABCD1 p.Asp194His 11063720:137:127
status: NEW138 Northern blot analysis of HeLa-D194H cells at different levels of induction revealed that the amount of endogenous ALD mRNA remains constant, independent of the level of overexpression of mutated ALD mRNA.
X
ABCD1 p.Asp194His 11063720:138:31
status: NEW148 However, direct interaction between D194H mutated ALDP and normal ALDP is still hypothetical and there is no direct evidence that such heterodimers are completely non-functional.
X
ABCD1 p.Asp194His 11063720:148:36
status: NEW149 Of the three mutations analysed in transient transfection assays, N148S and S213C are located in transmembrane domains, whereas D194H is in the first cytosolic loop of the ALDP (Fig. 6).
X
ABCD1 p.Asp194His 11063720:149:128
status: NEW150 In yeast two-hybrid experiments performed with ALDP lacking the N-terminal 361 amino acids, homodimers still formed (13), arguing against the possibility that the three mutations N148S, D194H and S213C interfere with dimerization of ALDP.
X
ABCD1 p.Asp194His 11063720:150:186
status: NEW155 Missense mutations N148S and S213C are both located within putative transmembrane domains and D194H is located in the first cytosolic loop.
X
ABCD1 p.Asp194His 11063720:155:94
status: NEW160 Three different fibroblast cell lines described as having normal levels of non-functional ALDP were obtained: fibroblasts N148S (26-29, patient 55 in ref. 26) were kindly provided by Dr Aubourg (Paris), D194H (kindred no.
X
ABCD1 p.Asp194His 11063720:160:203
status: NEW169 To introduce the point mutation D194H into the pTRE-ALD expression plasmid, in vitro mutagenesis was performed using QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA).
X
ABCD1 p.Asp194His 11063720:169:32
status: NEW176 For stable transfection of 1 × 106 HeLa Tet-on cells, 40 µg of D194H-ALD expression plasmid plus 2 µg of hygromycin resistance-conferring plasmid (pTK-Hyg; Clontech) were co-transfected at 220 V with a capacitance of 950 µF (Gene pulser and capacitance extender plus; BioRad, Hercules, CA) in 0.4 cm cuvettes.
X
ABCD1 p.Asp194His 11063720:176:71
status: NEW180 Identification of transfected clones by PCR DNA from 24 HeLa Tet-on clones was subjected to PCR analysis, resulting in two fragments of different sizes: the endogenously expressed genomic ALD DNA was amplified as a 334 bp fragment (including 145 bp from intron 6) whereas clones with the D194H-ALD cDNA gave an additional fragment of 189 bp.
X
ABCD1 p.Asp194His 11063720:180:288
status: NEW182 Of 24 clones analysed, 10 carried the mutated D194H-ALD cDNA.
X
ABCD1 p.Asp194His 11063720:182:46
status: NEW185 Finally, one clone, HeLa-D194H, was selected that showed high inducibility and no background expression.
X
ABCD1 p.Asp194His 11063720:185:25
status: NEW186 Northern blot D194H-ALDP expression was induced by different doxycycline concentrations.
X
ABCD1 p.Asp194His 11063720:186:14
status: NEW
PMID: 16412981
[PubMed]
Gueugnon F et al: "A novel cell model to study the function of the adrenoleukodystrophy-related protein."
No.
Sentence
Comment
43
This mutation in ALDRP, located in a region highly conserved between ALDRP and ALDP, corresponds to the D194H mutation in ALDP, a mutation found in X-ALD patients (see www.x-ald.nl), which disrupts the function without alteration of the peroxisomal localization and probably of the dimerization ability [30].
X
ABCD1 p.Asp194His 16412981:43:104
status: NEW214 The D207H mutation in ALDRP is similar to the D194H mutation in ALDP that has been previously studied by stable transfection and has been shown to disrupt function without suppressing the capacity of dimerization and of import in the peroxisomal membrane [30].
X
ABCD1 p.Asp194His 16412981:214:46
status: NEW
PMID: 7825602
[PubMed]
Ligtenberg MJ et al: "Spectrum of mutations in the gene encoding the adrenoleukodystrophy protein."
No.
Sentence
Comment
85
The mutation T1045C created a novel HpaII site, which was confirmed Table 2 Mutations in the Putative ALD Gene in Patients Studied Genomic- Kindred Type of Mutation and Amino Acid Genomic-PCR Mutation Reference cDNA Alterationa Alterationb Exonc Primers Detectiond Phenotype' Number Missense: C696Tf ................ R104C (R) 1 303F + 821R 303F, 821R AMN 17 G832A ................ S149N (N) 1 702F + 1145R 702F, 931R AMN 8 G841C ................ R152P (K) 1 702F + 1145R 702F, 931R ChALD 27 G874Af ................ R163H (R) 1 702F + 931R 702F, 931R SympCar 14 G966C ................ D194H (D) 1 685F + 1145R 914F, 1145R ChALD 12 T1045C ................ L220P (L) 1 914F + 1145R HpaII AMN 7 G1182A ................. G266R (G) 1 702F + 1231R 914F,1231R AMN 24 G1552A ................. R389H (R) 3 1479F + 1861R 1479F,1752R AMN 20 (2X): G2211A................. E609K(E) 8 544F*+ 1078R*h 544F*, 876R* AMN 13,18 A2212G ................ E609G (E) 8 544F*+ 1078R*h 544F*, 876R* ChALD 5 C2235Tf................ R617C (R) 8 544F* + 2742R 544F*, 876R* ChALD 23 C2364Tf................ R660W (R) 9 544F* + 2742R 2312F, 1078R* AMN 21 Amino acid deletion: del 2355-2357 ........... del 1657(V) 9 849F* + 2478Rh 2312F,1078R* ChALD 6 Nonsense: C783Tf ................ Q133h 1 702F + 931R 702F, 931R ChALD 26 G797A ................ W137h 1 685F +1145R 702F,931R ChALD 10 C855T ................ Q157h 1 702F + 1145R 702F,931R AMN 9 C929A ................ Y181h 1 702F + 1145R HpaIl ChALD 15 Frameshift: delC442 ................ A19> 1 303F + 821R 303F,593R ChALD 2 del C663 ................ G92> 1 303F + 840R 576F, 821R ChALD 22 dell71-1178 ........... F261> 1 702F + 1231R 914F,1231R ChALD 28 (4X): del 1801-1802 ........... E471> 5 1781F + 1861R Polyacrylamide gel ChALD, AMN 3,4,16,25 alt 1989-2377 ........... P534> 6-9 1890F +2669R 1890F,1078R* AMN 11 Splice defect: de12021-2054 ........... R545> SA 7 1880F +2132R 1880F,2114R ChALD 1 ins 8 bp 2251f ............ R622> SA 9 849F* + 1078R*h 849F*, 1078R* AMN 19 a Nucleotide numbers refer to Mosser et al. (1993), EMBL database Z21876.
X
ABCD1 p.Asp194His 7825602:85:588
status: NEW